Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lithium Carbonate for Chemotherapy-Induced Neutropenia in Breast Cancer
NCT05221593Phase 3Completed
- Sponsor
- Al-Azhar University
- Start
- Aug 2020
- Primary completion
- Apr 2022
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 3 trial of lithium carbonate in chemotherapy-induced neutropenia (CIN), sponsored by Al-Azhar University. Started Aug 2020; status: completed.
02
Drugs
lithium carbonate
03
Conditions
chemotherapy-induced neutropenia (CIN)
Beyond the preview
Go deeper on NCT05221593.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05221593.